Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Shain

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Blood|June 16, 2012
Metastatic myeloma?Kenneth Shain
International Journal of Genomics|December 19, 2017
Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical ReviewTaiga Nishihori, Kenneth Shain
Blood|January 22, 2026
High CTC, high-risk cytogenetics: a dangerous duo in MM?Kenneth Shain, Rachid Baz
Journal of Visualized Experiments : Jove|August 15, 2015
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma CellsAriosto Silva, Timothy Jacobson, Mark Meads, et al.
Seminars in Hematology|June 11, 2004
Targeting the bone marrow microenvironment in hematologic malignanciesWilliam S Dalton, Lori Hazlehurst, Kenneth Shain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIPLia Elena Perez, Nancy Parquet, Kenneth Shain, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Multiple Myeloma: New Insights and Therapeutic ApproachesKenneth C. Anderson, Robert A. Kyle, William S. Dalton, et al.
European Journal of Haematology|January 21, 2015
An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myelomaTaiga Nishihori, Rachid Baz, Kenneth Shain, et al.
Cancer Research|December 7, 2013
A preclinical assay for chemosensitivity in multiple myelomaZayar P Khin, Maria L C Ribeiro, Timothy Jacobson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Stemness of B-cell progenitors in multiple myeloma bone marrowKelly Boucher, Nancy Parquet, Raymond Widen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Blood|June 16, 2012
Metastatic myeloma?Kenneth Shain
International Journal of Genomics|December 19, 2017
Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical ReviewTaiga Nishihori, Kenneth Shain
Blood|January 22, 2026
High CTC, high-risk cytogenetics: a dangerous duo in MM?Kenneth Shain, Rachid Baz
Journal of Visualized Experiments : Jove|August 15, 2015
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma CellsAriosto Silva, Timothy Jacobson, Mark Meads, et al.
Seminars in Hematology|June 11, 2004
Targeting the bone marrow microenvironment in hematologic malignanciesWilliam S Dalton, Lori Hazlehurst, Kenneth Shain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIPLia Elena Perez, Nancy Parquet, Kenneth Shain, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Multiple Myeloma: New Insights and Therapeutic ApproachesKenneth C. Anderson, Robert A. Kyle, William S. Dalton, et al.
European Journal of Haematology|January 21, 2015
An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myelomaTaiga Nishihori, Rachid Baz, Kenneth Shain, et al.
Cancer Research|December 7, 2013
A preclinical assay for chemosensitivity in multiple myelomaZayar P Khin, Maria L C Ribeiro, Timothy Jacobson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Stemness of B-cell progenitors in multiple myeloma bone marrowKelly Boucher, Nancy Parquet, Raymond Widen, et al.
Pageof 3